Doebele R, et al. Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). IASLC 2018; abstract OA02.01.
Vaak specifieke DNA-afwijkingen bij atypische tumoren Lynch-syndroom
apr 2023 | Gynaecologische oncologie, Immuuntherapie, Maag-darm-leveroncologie